+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmacyclics llc - logo

Pharmacyclics LLC focuses on developing novel therapies for the treatment of cancer and immune-mediated diseases in the United States. The company markets IMBRUVICA, a single-agent therapy used for the treatment of patients with chronic lymphocytic leukemia, mantle cell lymphoma and waldenström's macroglobulinemia. It also has several product candidates in clinical development. The company was founded in 1991 and is headquartered in Sunnyvale, California.

From
From
Diffuse Large B Cell Lymphoma - Pipeline Insight, 2021 - Product Thumbnail Image

Diffuse Large B Cell Lymphoma - Pipeline Insight, 2021

  • Clinical Trials
  • June 2021
  • 60 Pages
From
From
From
From
Mantle Cell Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Mantle Cell Lymphoma - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
From
From
Factor VIIa Inhibitor - Pipeline Insight, 2022 - Product Thumbnail Image

Factor VIIa Inhibitor - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
From
From
From
From
From
Loading Indicator